25 Years at AB|29 Years of Experience
Erik Turenchalk was appointed Portfolio Manager for US Small and Mid Cap Value Equities in January 2020. From 2012 to 2019, he was a senior research analyst on the Small and Mid Cap Value team, responsible for covering industrial companies. Turenchalk was also the global industrials sector leader from 2017 to 2019. He joined the firm in 1999, and was promoted to research analyst in 2005. From 1999 to 2007, Turenchalk worked on the Advanced Value hedge-fund team, primarily researching short-position ideas with an emphasis on the consumer-cyclicals sector. In 2007, he relocated to London to support the firm’s international hedge-fund offerings. In 2010, Turenchalk returned to New York to oversee the research of short positions for the domestic hedge-fund portfolios. In 2012, he joined the Small and Mid Cap Value team. Prior to joining the firm, Turenchalk was a business analyst at Pratt & Whitney, a United Technologies company. He holds a BS in business administration with a concentration in finance from the University of Connecticut, and is a CFA charterholder. Location: New York
Today’s value stocks offer a magnificent mix of quality, forward-looking profitable firms.
James MacGregor, Cem Inal, Erik Turenchalk | 29 May 2024How can investors identify companies that can adapt their processes to compete in a less globalized world?
Erik Turenchalk, James MacGregor | 04 May 2022US small-cap value stocks have enjoyed considerable success since value stocks began to outperform growth in October 2020. Even after the recent rally, we believe several forces will continue to drive the recovery in the months, and possibly years, ahead.
Erik Turenchalk, James MacGregor | 19 April 2021Small-cap US stocks rebounded sharply in the fourth quarter. Yet the recovery may still be in its early stages-particularly for smaller-cap value stocks-as pandemic risks recede and earnings drivers kick in during 2021.
Erik Turenchalk, James MacGregor | 12 January 2021Smaller stocks offer diversification benefits and investment opportunities that can't be found in their larger brethren. But because large-cap stocks have been so popular for the last 10 years, many investors have missed out on the compelling stories and advantages smaller companies can provide. Our research aims to shine some light on the universe of smaller stocks by examining their perceived risks, performance drivers and return potential-particularly amid a recovery from the COVID-19 pandemic and recession. The time is right for investors to consider smaller investments that have the potential to sparkle.
Samantha S. Lau, Erik Turenchalk, James MacGregor | 12 November 2020As concerns about inflation spread, it's time to gauge how different types of stocks will respond. Smaller companies in niche markets may be better positioned to cope with rising prices-especially in consolidating industries.
James MacGregor, Shri Singhvi, Erik Turenchalk | 07 May 2018This website is authorized for use only by registered broker-dealers and is not authorized for use by the general public. The material contained herein is not for inspection by, distribution or quotation to, the general public. The sale of shares of AllianceBernstein funds may be restricted in certain jurisdictions. In particular, shares may not be offered or sold, directly or indirectly, in the United States or to US persons, as is more fully described in the prospectus with respect to each fund. Shares of AllianceBernstein funds are offered only pursuant to the fund's current prospectus together with the most recent financial statements. The information on this page is for information purposes only and should not be construed as an offer to sell, or solicitation to buy, or a recommendation for the securities of any AllianceBernstein fund.
AllianceBernstein provides its investment management services in Canada through its affiliates Sanford C. Bernstein & Co. LLC and AllianceBernstein Canada, Inc. Shares of the AllianceBernstein Luxembourg funds described herein are not registered in Canada for public sale to Canadian resident investors.